Latest Health News from Duke Medicine News and Communications
Search News
For Journalists
Reporters & producers can visit Duke Medicine News and Communications for contact information.
Parenting and home environment influence children’s exercise and eating habits
June 18, 2013
Kids whose moms encourage them to exercise and eat well, and model those healthy behaviors themselves, are more likely to be active and healthy eaters, according to researchers at Duke Medicine.
Osteoporosis Drug Stops Growth of Breast Cancer Cells, Even in Resistant Tumors
June 15, 2013
A drug approved in Europe to treat osteoporosis has now been shown to stop the growth of breast cancer cells, even in cancers that have become resistant to current targeted therapies, according to a Duke Cancer Institute study.
Duke Medicine appoints new Chief Information Officer
June 13, 2013
Duke Medicine Chief Medical Information Officer Jeffrey Ferranti, M.D., has been appointed the organization's Chief Information Officer and Vice President for Medical Informatics.
Re-Analysis of Diabetes Drug Finds No Higher Heart Attack Risk
June 6, 2013
A re-analysis of the data from a pivotal study of rosiglitazone found no increased risk of cardiovascular events associated with the controversial diabetes drug, according to researchers at the Duke Clinical Research Institute (DCRI).
Surgeons at Duke University Hospital Implant Bioengineered Vein
June 6, 2013
n a first-of-its-kind operation in the United States, a team of doctors at Duke University Hospital helped create a bioengineered blood vessel and transplanted it into the arm of a patient with end-stage kidney disease.
Duke to Co-Lead NIH Research Network on Antibacterial Resistance
June 3, 2013
Investigators at Duke Medicine and the University of California, San Francisco (UCSF) have been selected to oversee a nationwide research program on antibacterial resistance, which includes a focus on the growing unmet challenges associated with methicillin-resistant Staphylococcus aureus (MRSA) and E. coli.
Poliovirus Vaccine Trial Shows Early Promise for Recurrent Glioblastoma
May 21, 2013
An attack on glioblastoma brain tumor cells that uses a modified poliovirus is showing encouraging results in an early study to establish the proper dose level, researchers at Duke Cancer Institute report.
Antidepressant reduces stress-induced heart condition
May 21, 2013
A drug commonly used to treat depression and anxiety may improve a stress-related heart condition in people with stable coronary heart disease, according to researchers at Duke Medicine.
Doctors should discuss financial concerns of cancer patients
May 16, 2013
Most cancer patients would like to talk about the cost of their care with their doctors, but often don't because they fear the discussion could compromise the quality of their treatment, researchers at Duke Cancer Institute report.
Kernodle Clinic Physicians to Become Part of Duke Medicine’s Faculty Practice Group
May 15, 2013
The physicians of Kernodle Clinic, Inc., one of the Triad region’s premier multi-specialty medical practices, have joined the Private Diagnostic Clinic (PDC), Duke Medicine’s physician practice organization.
June 18, 2013
Kids whose moms encourage them to exercise and eat well, and model those healthy behaviors themselves, are more likely to be active and healthy eaters, according to researchers at Duke Medicine.
Osteoporosis Drug Stops Growth of Breast Cancer Cells, Even in Resistant Tumors
June 15, 2013
A drug approved in Europe to treat osteoporosis has now been shown to stop the growth of breast cancer cells, even in cancers that have become resistant to current targeted therapies, according to a Duke Cancer Institute study.
Duke Medicine appoints new Chief Information Officer
June 13, 2013
Duke Medicine Chief Medical Information Officer Jeffrey Ferranti, M.D., has been appointed the organization's Chief Information Officer and Vice President for Medical Informatics.
Re-Analysis of Diabetes Drug Finds No Higher Heart Attack Risk
June 6, 2013
A re-analysis of the data from a pivotal study of rosiglitazone found no increased risk of cardiovascular events associated with the controversial diabetes drug, according to researchers at the Duke Clinical Research Institute (DCRI).
Surgeons at Duke University Hospital Implant Bioengineered Vein
June 6, 2013
n a first-of-its-kind operation in the United States, a team of doctors at Duke University Hospital helped create a bioengineered blood vessel and transplanted it into the arm of a patient with end-stage kidney disease.
Duke to Co-Lead NIH Research Network on Antibacterial Resistance
June 3, 2013
Investigators at Duke Medicine and the University of California, San Francisco (UCSF) have been selected to oversee a nationwide research program on antibacterial resistance, which includes a focus on the growing unmet challenges associated with methicillin-resistant Staphylococcus aureus (MRSA) and E. coli.
Poliovirus Vaccine Trial Shows Early Promise for Recurrent Glioblastoma
May 21, 2013
An attack on glioblastoma brain tumor cells that uses a modified poliovirus is showing encouraging results in an early study to establish the proper dose level, researchers at Duke Cancer Institute report.
Antidepressant reduces stress-induced heart condition
May 21, 2013
A drug commonly used to treat depression and anxiety may improve a stress-related heart condition in people with stable coronary heart disease, according to researchers at Duke Medicine.
Doctors should discuss financial concerns of cancer patients
May 16, 2013
Most cancer patients would like to talk about the cost of their care with their doctors, but often don't because they fear the discussion could compromise the quality of their treatment, researchers at Duke Cancer Institute report.
Kernodle Clinic Physicians to Become Part of Duke Medicine’s Faculty Practice Group
May 15, 2013
The physicians of Kernodle Clinic, Inc., one of the Triad region’s premier multi-specialty medical practices, have joined the Private Diagnostic Clinic (PDC), Duke Medicine’s physician practice organization.
